Johnson and Johnson has declared that it will begin human trials of its potential coronavirus vaccine in the second half of July. This will be done two months earlier than they had planned due to the drugmakers race to develop a vaccine for the deadly virus. The company has already signed deals with the US government and will produce more than 1 billion doses of the vaccine through 2021.
Currently, there is no approved treatment or vaccine available for treating Covid 19 which has caused 4,00,000 deaths throughout the world. The safety of the vaccine and immune response will be tried out on 1045 healthy people aged between 18 and 55 years and also those who are 65 and older. The trials will begin in the United States and in Belgium. Currently there are about 10 vaccines for the virus which are being tested on humans.